Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Impact Of Nurse Navigation Program on Outcomes in Patients With GI Cancers

A Randomized, Controlled Prospective Trial Evaluating The Impact Of A Nurse Navigation Program on Patients With Gastrointestinal Cancers Undergoing Oncological Treatment

Outcome
Primary endpoint: no statistically significant difference in all 2 posted analyses (first: Coefficient of negative binomial model 0.0547 (95% CI -0.3680 to 0.4773); p = 0.80, as posted; posted threshold 0.025)
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
3 November 2020
Ended
10 August 2023
Enrollment
228 participants
Sites
1
Primary outcomes
Annualized Count of Acute Care Visits; Proportion of Participants Surviving at 6 Months
Sponsor type
Academic / other
Results posted
30 January 2025
Last update
30 January 2025

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Results

Primary endpoint
Primary endpoint: no statistically significant difference in all 2 posted analyses (first: Coefficient of negative binomial model 0.0547 (95% CI -0.3680 to 0.4773); p = 0.80, as posted; posted threshold 0.025)As posted on ClinicalTrials.gov ↗, registry record of 30 January 2025
Primary outcome
Annualized Count of Acute Care VisitsStandard of Care: 3 (0 to 9.6), n = 87Oncology Nurse Navigation: 3.8 (1.3 to 7.7), n = 95Standard of Care vs Oncology Nurse Navigation: Coefficient of negative binomial model 0.0547 (95% CI -0.3680 to 0.4773); p = 0.80; Regression, Negative binomial (not statistically significant against the posted threshold 0.025; outcome 1, analysis 1)Values: median unplanned acute care visits in one year, Inter-Quartile RangeTime frame: From the date of randomization until subject discontinued the intervention, assessed up to 34 months
Primary outcome
Proportion of Participants Surviving at 6 MonthsStandard of Care: 52 of 87Oncology Nurse Navigation: 58 of 95Standard of Care vs Oncology Nurse Navigation: p = 0.88; Fisher Exact (not statistically significant against the posted threshold 0.025; outcome 2, analysis 1)Values: ParticipantsTime frame: From the date of randomization to death or 6 months
Participants
Standard of Care: 115 started, 115 completedOncology Nurse Navigation: 113 started, 113 completed
Serious adverse events
Standard of Care: 0 of 0Oncology Nurse Navigation: 0 of 0Participants with at least one serious adverse event, of those at risk, as posted
7 secondary outcomes
Proportion of Participants Surviving at 12 Months
Standard of Care 23/87; Oncology Nurse Navigation 28/95 [Participants] Standard of Care vs Oncology Nurse Navigation: p = 0.74; Fisher Exact
Hospital Length of Stay
Standard of Care 1 (0 to 10), n=87; Oncology Nurse Navigation 4 (0 to 92), n=95 [median Days, Inter-Quartile Range] Standard of Care vs Oncology Nurse Navigation: Coefficient of negative binomial model 0.1574 (95% CI -0.3905 to 0.7054); p = 0.57; Regression, Negative binomial
Time From Hospice Referral to Death for Participants Referred to Hospice
Standard of Care 0.427 (0.263 to 0.755), n=39; Oncology Nurse Navigation 0.526 (0.296 to 1.084), n=43 [median months, 95% Confidence Interval] Standard of Care vs Oncology Nurse Navigation: Hazard Ratio (HR) 0.864 (95% CI 0.570 to 1.309); p = 0.45; Log Rank
Total Number of 30-day Readmissions
Standard of Care 0 (0 to 1), n=51; Oncology Nurse Navigation 0 (0 to 1), n=64 [median number of 30-day readmissions, Inter-Quartile Range] Standard of Care vs Oncology Nurse Navigation: Coefficient of negative binomial model -0.4194 (95% CI -1.0763 to 0.2374); p = 0.21; Regression, Negative binomial
Proportion of Participants Referred to Supportive Care Services
Standard of Care 22/87; Oncology Nurse Navigation 50/95 [Participants] Standard of Care vs Oncology Nurse Navigation: Odds Ratio (OR) 3.28 (95% CI 1.75 to 6.15); p < 0.01; Regression, Logistic
Proportions of Missed Visits of All Scheduled Visits From 0% to 100%.
Standard of Care 3.1 (0.0 to 47.6), n=87; Oncology Nurse Navigation 2.2 (0.0 to 60.0), n=95 [median percentage of missed scheduled visits, Full Range] Standard of Care vs Oncology Nurse Navigation: Slope -2.6939 (95% CI -5.9538 to 0.5659); p = 0.11; Regression, Linear
Average Score of Subject Satisfaction as Assessed by an Adaptation of the EORTC PATSAT C33
Standard of Care 4.4 (0.6), n=35; Oncology Nurse Navigation 4.6 (0.5), n=51 [mean score on a scale (out of 5), Standard Deviation] Standard of Care vs Oncology Nurse Navigation: Slope 0.1197 (95% CI -0.0315 to 0.4378); p = 0.09; Regression, Linear

Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The purpose of this study is to learn about the impact of the Oncology Nurse Navigation program on the frequency of Emergency Department, urgent care visits and inpatient hospital admissions; and overall survival rate at 6 months. The investigators aim to understand if prompt and effective coordination of care provided by Oncology Nurse Navigation (ONN) service will reduce the number of avoidable, unplanned ED visits and hospitalizations, as well as adding measurable value to cancer care, and improve patient overall survival.

Detailed description public domain (ClinicalTrials.gov)

A randomized controlled prospective trial evaluating the effectiveness of a nurse navigation program for gastrointestinal cancer patients undergoing oncological treatment. Upon accrual, patients will be randomized 1:1 to receive standard of care plus ONN service (n = 107) or standard of care only (without ONN service; n = 107). Patients in both arms will be assessed for acute care utilization and overall survival (OS) rate at 6 months. Anticipated accrual period will be 30 months.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Annualized Count of Acute Care Visits [From the date of randomization until subject discontinued the intervention, assessed up to 34 months]. Median, unplanned acute care visits in one year (Inter-Quartile Range). Standard of Care (n=87): 3 (0 to 9.6); Oncology Nurse Navigation (n=95): 3.8 (1.3 to 7.7). Analysis, Standard of Care vs Oncology Nurse Navigation: Coefficient of negative binomial model 0.0547 (95% CI -0.3680 to 0.4773); p=0.80; Regression, Negative binomial; superiority.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Proportion of Participants Surviving at 6 Months [From the date of randomization to death or 6 months]. Count Of Participants, Participants. Standard of Care (n=87): 52; Oncology Nurse Navigation (n=95): 58. Analysis, Standard of Care vs Oncology Nurse Navigation: p=0.88; Fisher Exact; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Proportion of Participants Surviving at 12 Months [From the date of randomization up until 12 months]. Count Of Participants, Participants. Standard of Care (n=87): 23; Oncology Nurse Navigation (n=95): 28. Analysis, Standard of Care vs Oncology Nurse Navigation: p=0.74; Fisher Exact; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Hospital Length of Stay [From the date of randomization until subject discontinued the intervention, assessed up to 34 months]. Median, Days (Inter-Quartile Range). Standard of Care (n=87): 1 (0 to 10); Oncology Nurse Navigation (n=95): 4 (0 to 92). Analysis, Standard of Care vs Oncology Nurse Navigation: Coefficient of negative binomial model 0.1574 (95% CI -0.3905 to 0.7054); p=0.57; Regression, Negative binomial; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Time From Hospice Referral to Death for Participants Referred to Hospice [From the date of hospice referral to death or last follow-up, assessed over 7 months.]. Median, months (95% Confidence Interval). Standard of Care (n=39): 0.427 (0.263 to 0.755); Oncology Nurse Navigation (n=43): 0.526 (0.296 to 1.084). Analysis, Standard of Care vs Oncology Nurse Navigation: Hazard Ratio (HR) 0.864 (95% CI 0.570 to 1.309); p=0.45; Log Rank; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Total Number of 30-day Readmissions [From the date of randomization until subject discontinued the intervention, assessed up to 34 months]. Median, number of 30-day readmissions (Inter-Quartile Range). Standard of Care (n=51): 0 (0 to 1); Oncology Nurse Navigation (n=64): 0 (0 to 1). Analysis, Standard of Care vs Oncology Nurse Navigation: Coefficient of negative binomial model -0.4194 (95% CI -1.0763 to 0.2374); p=0.21; Regression, Negative binomial; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Proportion of Participants Referred to Supportive Care Services [From the date of randomization until subject discontinued the intervention, assessed up to 34 months]. Count Of Participants, Participants. Standard of Care (n=87): 22; Oncology Nurse Navigation (n=95): 50. Analysis, Standard of Care vs Oncology Nurse Navigation: Odds Ratio (OR) 3.28 (95% CI 1.75 to 6.15); p=<0.01; Regression, Logistic; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Proportions of Missed Visits of All Scheduled Visits From 0% to 100%. [From the date of randomization until subject discontinued the intervention, assessed up to 34 months]. Median, percentage of missed scheduled visits (Full Range). Standard of Care (n=87): 3.1 (0.0 to 47.6); Oncology Nurse Navigation (n=95): 2.2 (0.0 to 60.0). Analysis, Standard of Care vs Oncology Nurse Navigation: Slope -2.6939 (95% CI -5.9538 to 0.5659); p=0.11; Regression, Linear; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Average Score of Subject Satisfaction as Assessed by an Adaptation of the EORTC PATSAT C33 [From the date of randomization up until 14 weeks]. Mean, score on a scale (out of 5) (Standard Deviation). Standard of Care (n=35): 4.4 (0.6); Oncology Nurse Navigation (n=51): 4.6 (0.5). Analysis, Standard of Care vs Oncology Nurse Navigation: Slope 0.1197 (95% CI -0.0315 to 0.4378); p=0.09; Regression, Linear; superiority.